RARE
Ultragenyx Pharmaceutical Inc. · Healthcare
Chief Financial Officer Howard Horn sold $156K of Ultragenyx Pharmaceutical Inc.
Sold$155,645
$33.13Price
4,698Shares
−4%Stake
What RARE did after the filing
- The stock from Mon, Jul 6 close, $33.70
- −24.4%
- S&P 500, same days
- +2.2%
Measured over 30 trading days, to the Aug 18 close.
Traded Wed, Jul 1. Filed Mon, Jul 6, 3:37 PM ET, during the session. Returns use the Jul 6 close and the Aug 18 close. Not investment advice.